Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hand Hygiene | 7 | 2025 | 13 | 2.070 |
Why?
|
| Infection Control | 6 | 2025 | 134 | 1.520 |
Why?
|
| Guideline Adherence | 4 | 2025 | 249 | 1.190 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 2 | 2016 | 5 | 0.990 |
Why?
|
| Cross Infection | 6 | 2025 | 155 | 0.930 |
Why?
|
| Attitude of Health Personnel | 5 | 2021 | 684 | 0.850 |
Why?
|
| Anaphylaxis | 1 | 2023 | 29 | 0.770 |
Why?
|
| Disease Outbreaks | 3 | 2021 | 148 | 0.640 |
Why?
|
| Communicable Diseases | 2 | 2023 | 74 | 0.610 |
Why?
|
| Simulation Training | 1 | 2019 | 117 | 0.530 |
Why?
|
| Hand Disinfection | 2 | 2021 | 18 | 0.530 |
Why?
|
| Drug Utilization | 1 | 2016 | 65 | 0.480 |
Why?
|
| Sorbitol | 1 | 2016 | 9 | 0.470 |
Why?
|
| Foodborne Diseases | 1 | 2016 | 9 | 0.470 |
Why?
|
| APACHE | 1 | 2015 | 24 | 0.450 |
Why?
|
| Health Personnel | 4 | 2021 | 257 | 0.430 |
Why?
|
| Gastrointestinal Diseases | 1 | 2016 | 155 | 0.420 |
Why?
|
| Social Media | 1 | 2016 | 119 | 0.420 |
Why?
|
| Human Activities | 1 | 2013 | 12 | 0.410 |
Why?
|
| Education, Medical | 1 | 2016 | 229 | 0.400 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 43 | 0.400 |
Why?
|
| Telemetry | 1 | 2013 | 30 | 0.400 |
Why?
|
| Clostridium Infections | 3 | 2023 | 131 | 0.390 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 523 | 0.360 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 601 | 0.360 |
Why?
|
| Hospital Mortality | 1 | 2015 | 518 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 876 | 0.360 |
Why?
|
| Patient Discharge | 1 | 2015 | 380 | 0.350 |
Why?
|
| Critical Care | 1 | 2015 | 462 | 0.340 |
Why?
|
| Intensive Care Units | 1 | 2015 | 473 | 0.340 |
Why?
|
| Influenza, Human | 3 | 2018 | 357 | 0.260 |
Why?
|
| Humans | 29 | 2025 | 97898 | 0.230 |
Why?
|
| Hospitals | 4 | 2025 | 335 | 0.230 |
Why?
|
| Influenza Vaccines | 2 | 2018 | 176 | 0.220 |
Why?
|
| Universities | 1 | 2021 | 166 | 0.160 |
Why?
|
| Emergency Service, Hospital | 2 | 2023 | 619 | 0.150 |
Why?
|
| Students | 1 | 2021 | 196 | 0.150 |
Why?
|
| Patient Transfer | 1 | 2020 | 111 | 0.150 |
Why?
|
| Warts | 1 | 2019 | 12 | 0.140 |
Why?
|
| Heterocyclic Compounds | 1 | 2019 | 21 | 0.140 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2019 | 38 | 0.140 |
Why?
|
| Academic Medical Centers | 3 | 2020 | 407 | 0.140 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 122 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 49 | 0.140 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2018 | 22 | 0.140 |
Why?
|
| Chicago | 3 | 2021 | 1513 | 0.140 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 90 | 0.130 |
Why?
|
| Bone Marrow | 1 | 2019 | 420 | 0.130 |
Why?
|
| Candida | 1 | 2016 | 20 | 0.120 |
Why?
|
| Drug Resistance, Microbial | 1 | 2016 | 63 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2019 | 318 | 0.120 |
Why?
|
| Culture Techniques | 1 | 2016 | 80 | 0.120 |
Why?
|
| Candidiasis | 1 | 2016 | 40 | 0.120 |
Why?
|
| Disinfection | 1 | 2016 | 14 | 0.120 |
Why?
|
| Organ Transplantation | 1 | 2020 | 306 | 0.120 |
Why?
|
| Technology | 1 | 2016 | 31 | 0.120 |
Why?
|
| Equipment Contamination | 1 | 2016 | 28 | 0.120 |
Why?
|
| Hospitals, University | 1 | 2016 | 192 | 0.120 |
Why?
|
| Food Service, Hospital | 1 | 2016 | 4 | 0.120 |
Why?
|
| Endosonography | 1 | 2016 | 103 | 0.110 |
Why?
|
| Civil Defense | 1 | 2015 | 11 | 0.110 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 12 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 341 | 0.110 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 60 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 337 | 0.110 |
Why?
|
| Fungi | 1 | 2015 | 70 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 3021 | 0.110 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 87 | 0.110 |
Why?
|
| Cystectomy | 1 | 2015 | 124 | 0.110 |
Why?
|
| Radio Frequency Identification Device | 1 | 2013 | 4 | 0.100 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2013 | 17 | 0.100 |
Why?
|
| Public Health | 1 | 2015 | 161 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2019 | 863 | 0.100 |
Why?
|
| Intention | 1 | 2013 | 55 | 0.100 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 251 | 0.090 |
Why?
|
| Bacteria | 1 | 2017 | 545 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1944 | 0.090 |
Why?
|
| Research Design | 1 | 2016 | 650 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1778 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 401 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 116 | 0.080 |
Why?
|
| Registries | 1 | 2016 | 1120 | 0.080 |
Why?
|
| Pandemics | 3 | 2023 | 913 | 0.070 |
Why?
|
| United States | 4 | 2025 | 8184 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 478 | 0.070 |
Why?
|
| Students, Medical | 1 | 2013 | 449 | 0.070 |
Why?
|
| Fatal Outcome | 2 | 2019 | 295 | 0.060 |
Why?
|
| Male | 7 | 2021 | 47001 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2015 | 2680 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2013 | 1120 | 0.050 |
Why?
|
| Prevalence | 2 | 2020 | 1384 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 55 | 0.050 |
Why?
|
| Female | 6 | 2021 | 51470 | 0.050 |
Why?
|
| Travel-Related Illness | 1 | 2021 | 3 | 0.040 |
Why?
|
| Personnel, Hospital | 1 | 2021 | 31 | 0.040 |
Why?
|
| Medical Overuse | 1 | 2020 | 32 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 79 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2020 | 49 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 10953 | 0.040 |
Why?
|
| Critical Illness | 1 | 2023 | 360 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 7507 | 0.040 |
Why?
|
| Benzylamines | 1 | 2019 | 17 | 0.040 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2019 | 19 | 0.040 |
Why?
|
| Bone Marrow Examination | 1 | 2019 | 40 | 0.040 |
Why?
|
| Risk Factors | 2 | 2023 | 6225 | 0.040 |
Why?
|
| Eggs | 1 | 2018 | 14 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2020 | 182 | 0.030 |
Why?
|
| Ferrets | 1 | 2018 | 50 | 0.030 |
Why?
|
| Primary Myelofibrosis | 1 | 2019 | 72 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2018 | 116 | 0.030 |
Why?
|
| Dementia | 1 | 2020 | 226 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2018 | 123 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2018 | 83 | 0.030 |
Why?
|
| Propionibacterium | 1 | 2017 | 6 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2017 | 24 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 286 | 0.030 |
Why?
|
| Adult | 4 | 2023 | 29458 | 0.030 |
Why?
|
| Inpatients | 1 | 2020 | 367 | 0.030 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2016 | 3 | 0.030 |
Why?
|
| Aged | 4 | 2018 | 21704 | 0.030 |
Why?
|
| Child | 2 | 2023 | 7681 | 0.030 |
Why?
|
| Seasons | 1 | 2018 | 252 | 0.030 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2016 | 14 | 0.030 |
Why?
|
| Citrobacter freundii | 1 | 2016 | 2 | 0.030 |
Why?
|
| Hafnia alvei | 1 | 2016 | 2 | 0.030 |
Why?
|
| Klebsiella oxytoca | 1 | 2016 | 3 | 0.030 |
Why?
|
| Sphingomonas | 1 | 2016 | 4 | 0.030 |
Why?
|
| Stenotrophomonas maltophilia | 1 | 2016 | 3 | 0.030 |
Why?
|
| Pseudomonas putida | 1 | 2016 | 9 | 0.030 |
Why?
|
| Enterobacter cloacae | 1 | 2016 | 13 | 0.030 |
Why?
|
| Acinetobacter baumannii | 1 | 2016 | 29 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 2016 | 37 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 150 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2016 | 126 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 7387 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 349 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2017 | 419 | 0.030 |
Why?
|
| Middle Aged | 4 | 2019 | 29358 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2015 | 51 | 0.030 |
Why?
|
| Global Health | 1 | 2016 | 215 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 207 | 0.030 |
Why?
|
| Viruses | 1 | 2015 | 64 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 569 | 0.030 |
Why?
|
| China | 1 | 2015 | 277 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 894 | 0.020 |
Why?
|
| Phylogeny | 1 | 2018 | 1339 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 2638 | 0.020 |
Why?
|
| Microbiota | 1 | 2017 | 467 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 3202 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 208 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 301 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2080 | 0.020 |
Why?
|
| Illinois | 1 | 2011 | 522 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 369 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 4023 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1273 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 4112 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4799 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2011 | 437 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 4396 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 2529 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 3329 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 4000 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 28907 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 10081 | 0.010 |
Why?
|